Trevi Therapeutics (TRVI) Interest Coverage Ratio (QoQ) (2018 - 2026)
Trevi Therapeutics (TRVI) Interest Coverage Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Trevi Therapeutics | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.64% |
| Dec 31, 2025 | -96.05% |
| Sep 30, 2025 | -11.26% |
| Jun 30, 2025 | 78.78% |
| Mar 31, 2025 | 99.49% |
| Dec 31, 2024 | -18,672.54% |
| Sep 30, 2024 | -560.08% |
| Jun 30, 2024 | -18.09% |
| Mar 31, 2024 | 84.17% |
| Dec 31, 2023 | 59.68% |
| Sep 30, 2023 | -139.28% |
| Jun 30, 2023 | -67.33% |
| Mar 31, 2023 | -34.76% |
| Dec 31, 2022 | 15.59% |
| Sep 30, 2022 | -8.59% |
| Jun 30, 2022 | -13.96% |
| Mar 31, 2022 | -181.54% |
| Dec 31, 2021 | 224.43% |
| Sep 30, 2021 | 6.21% |
| Jun 30, 2021 | 11.15% |